Embolic Protection Devices Market Size By Product (Proximal Occlusion Systems, Distal Occlusion Systems, Distal Filters), By Application (Cardiovascular Disease, Peripheral Disease, Neurovascular Disease), By Material (Polyurethane, Nitinol), By End-use (Ambulatory Surgical Centers, Hospitals), Industry Analysis Report, Regional Outlook Growth Potential, Industry Analysis Report, Competitive Market Share & Forecast, 2022 – 2030

Industry Overview

Embolic Protection Devices Market size surpassed USD 1 billion in 2021 and is expected to grow at a CAGR of more than 8% from 2022 to 2030. Rising need for minimally invasive procedures around the world will propel market expansion.
 

Get more details on this report - Request Free Sample PDF
 

For minimally invasive stenting procedures, embolic protection devices are primarily utilized to obtain the blood and lumina debris that are released into the bloodstream, which may impel product penetration in cardiovascular treatment. Additionally, the growing preference for minimally invasive surgeries due to the lower probability of infection and surgical complications as compared to invasive procedures will bolster business revenue. Surging incidences of cardiovascular illnesses will be lucrative for the industry.
 

The expanding geriatric population in developing countries will also boost the embolic protection devices market size. Manufacturers in the industry are majorly engaging in product range expansion, increasing product reliability, investing in research & development activities, and executing strategic mergers & acquisitions to propel their business standing in the coming years, which is proving advantageous for the competitive landscape of the global market.
 

High availability of alternatives may restrain industry progression

The availability of alternatives is a major factor restraining market growth. The presence of options, especially at lower costs, may hamper the adoption of embolic protection devices. In developing nations, the affordability of other medical devices has hindered market value. To that end, access to indirect substitutes might negatively impact the industry share. Nonetheless, soaring investment in the government sector shall empower the market to overcome this issue.
 

Easy operation to push market demand

In terms of product, the embolic protection devices market is classified into proximal occlusion systems, distal occlusion systems, and distal filters. The distal occlusion systems segment was valued at more than USD 300 million in 2021 and is poised to showcase considerable progress over the forecast period. This is attributed to favorable qualities of distal filters viz., ease of use, availability of filters in different specifications, and non-interference with lesion visualization.
 

Rising cases of cardiovascular diseases to define the industry landscape

Get more details on this report - Request Free Sample PDF
 

Based on application, the embolic protection devices market is divided into neurovascular disease, cardiovascular disease, and peripheral disease. The cardiovascular disease segment accounted for a revenue of over USD 500 million in 2021. Escalating occurrences of heart-related disorders across the globe will spur the industry statistics. Moreover, prevalent utilization of embolic protection devices for stroke prevention and budding product demand in percutaneous coronary intervention (PCI), transcatheter aortic valve replacement (TAVR), and other cardiac interventions will foster segment outlook.
 

Shape-changing ability to help polyurethane segment gain traction

Based on material, the embolic protection devices market is categorized into nitinol and polyurethane. The polyurethane segment is anticipated to surpass USD 950 million by 2030. The extensive usage of polyurethane in the advancement of embolic medical devices for numerous minimally invasive biomedical applications will be beneficial for segment expansion. Furthermore, its ability to be stored in a secondary shape and regain its primary shape on exposure to external stimuli, such as water and heat, will spur its demand.
 

High-quality treatment in minimal time to accelerate market trends

With respect to end-use, the embolic protection devices market is segregated into ambulatory surgical centers, hospitals, and others. The ambulatory surgical centers segment is projected to cross USD 880 million by 2030. Various benefits provided by ambulatory surgical centers, such as affordable prices of quality treatments, short stays, and low risk of hospital-acquired infections, will push the business growth.
 

Changing lifestyle to aid North America emerge as a prominent revenue pocket

Get more details on this report - Request Free Sample PDF
 

 North America embolic protection devices market accounted for 35.5% business share in 2021 and is primed to depict significant growth in the upcoming years. The mounting patient population suffering from chronic diseases and the soaring preference for transcatheter aortic valve replacement procedures (TAVR) in the region will drive the industry landscape.
 

Furthermore, rising cases of obesity due to the shift in lifestyle, unhealthy dietary habits, and strong foothold of major industry players in the region will positively influence the North America market statistics. This will fuel the adoption of novel products and technologically advanced procedures amongst end-users, which will boost the development of the embolic protection devices industry.
 

Strategic alliances to strengthen industry outlook

Abbott Laboratories, Allium Medica, Boston Scientific Corporation, Cardinal Health, Contego Medical, LLC, Edwards Lifesciences Corporation, W. L. Gore & Associates (Gore Medical), Innovative Cardiovascular Solutions, LLC, Keystone Heart, Medtronic, Metactive Medical, and Transverse Medical, Inc. are some of the key manufacturers in the embolic protection devices market. These firms’ primary focus is on introducing reliable solutions with effective results. They also engage in strategic alliances to strengthen their market position.
 

Impact of COVID-19 on the embolic protection devices market trends

The outbreak of the COVID-19 pandemic created unprecedented challenges for industry growth. The number of PCI procedures declined massively as a result of the increasing number of COVID-19 cases. Additionally, burgeoning logistical disruptions amid the lockdowns resulted in manufacturing delays and disruption of the supply chain of embolic protection devices, which caused temporary shortages of the product globally. However, prevalent vaccination efforts and resumption of manufacturing activities are helping the industry gradually regain its pre-COVID momentum.
 

The embolic protection devices market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2030 for the following segments:

By Product

• Distal Occlusion Systems
• Distal Filters
• Proximal Occlusion Systems

By Application

• Neurovascular Disease
• Cardiovascular Disease
• Peripheral Disease

By Material

• Nitinol
• Polyurethane

By End-use

• Ambulatory Surgical Centers
• Hospitals
• Others

The above information is provided for the following regions and countries:

• North America
  • Canada
  • U.S.
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
• Latin America
  • Mexico
  • Brazil
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa